NCT04987944 - Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 18, 2021

Primary Completion Date

March 29, 2023

Study Completion Date

April 4, 2023

Conditions

Asthma

Interventions

DRUG

Zavegepant

150 mg BID

DRUG

Placebo

Placebo matching active drug

Trial Locations (10)

University of Calgary, Calgary

University of Calgary, Calgary

University of Alberta Hospital, Edmonton

The Lung Centre- Vancouver General Hospital, Vancouver

The Lung Centre-Vancouver General Hospital, Vancouver

McMaster University, Hamilton

McMaster Universtiy, Hamilton

Institut universitaire en cardiologie et pneumologie de Quebec-Universite Laval-(IUCPQ-UL), Québec

University of Saskatchewan/Royal University Hospital, Saskatoon